Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet
In This Article:
Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.
Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.